Prospective, randomized, back-to-back trial evaluating the usefulness of i-SCAN in screening colonoscopy - 21/04/12
Reprint requests: Won Hyeok Choe, MD, Associate Professor, Department of Internal Medicine, Konkuk University School of Medicine, 4-12 Hwayang-dong, Gwangjin-gu, Seoul, 143-729, Republic of KoreaRésumé |
Background |
The newly developed i-SCAN application can theoretically maximize the effectiveness of colonoscopy. However, the practical usefulness of the i-SCAN application during screening colonoscopy has not been assessed.
Objective |
To assess the efficacy of the i-SCAN application during screening colonoscopy.
Design |
A prospective, randomized trial that used a modified, back-to-back colonoscopy.
Setting |
Academic hospital.
Patients |
This study involved 389 asymptomatic, consecutive, average-risk patients who underwent screening colonoscopy.
Intervention |
The patients were randomized to the first withdrawal with either conventional high-definition white light (HDWL group; n = 119), i-SCAN contrast/surface enhancement (CE/SE) mode (i-SCAN1 group; n = 115), or i-SCAN CE/SE/tone enhancement-colorectal mode (i-SCAN2 group; n = 118). All patients underwent a second examination with HDWL as the criterion standard.
Main Outcome Measurements |
The primary outcome measurement was the adenoma detection rate and adenoma miss rate. The secondary outcome measurement was the accuracy of the histologic prediction of neoplastic and nonneoplastic polyps.
Results |
The adenoma detection rates during the first withdrawal of HDWL, i-SCAN1, and i-SCAN2 were 31.9%, 36.5%, and 33.1%, respectively (P = .742), and the adenoma miss rates of each group were 22.9%, 19.3%, and 15.9%, respectively (P = .513). Based on the multivariate analysis, the application of i-SCAN was not associated with an improvement in adenoma detection and the prevention of missed polyps. However, the prediction of neoplastic and nonneoplastic colorectal lesions was more precise in the i-SCAN2 group compared with the HDWL group (accuracy 79.3% vs 75.5%, P = .029; sensitivity 86.5% vs 72.6%, P = .020; and specificity 91.4% vs 80.6%, P = .040).
Limitations |
Single-center trial.
Conclusion |
i-SCAN during the screening colonoscopy may fail to improve adenoma detection and the prevention of missed polyps, but i-SCAN appears to be effective for real-time histologic prediction of polyps compared with conventional HDWL colonoscopy. (Clinical trial registration number: NCT01417611.)
Le texte complet de cet article est disponible en PDF.Abbreviations : CE, FICE, HDWL, NBI, NPV, SE, PPV, TE
Plan
| DISCLOSURE: This work was supported by Konkuk University in 2011. No other financial relationships relevant to this publication were disclosed. |
|
| If you would like to chat with an author of this article, you may contact Dr Choe at 20050101@kuh.ac.kr. |
Vol 75 - N° 5
P. 1011 - mai 2012 Retour au numéro
Article précédent
- Diagnostic yield of EUS-guided FNA and cytology in suspected tubercular intra-abdominal lymphadenopathy
- Rajesh Puri, Rakhee Mangla, Mohamad Eloubeidi, Peter Vilmann, Ragesh Thandassery, Randhir Sud
- Prevalence of advanced histological features in diminutive and small colon polyps
- Neil Gupta, Ajay Bansal, Deepthi Rao, Dayna S. Early, Sreenivasa Jonnalagadda, Sachin B. Wani, Steven A. Edmundowicz, Prateek Sharma, Amit Rastogi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?